Share Price and Basic Stock Data
Last Updated: January 10, 2026, 4:30 am
| PEG Ratio | -4.51 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bharat Rasayan Ltd operates within the agrochemical and pesticide sector, focusing on the production of a diverse range of crop protection products. The company reported a price of ₹2,175 and a market capitalization of ₹3,605 Cr. Over the last fiscal year, Bharat Rasayan’s sales figures showed fluctuations, with total sales for the trailing twelve months (TTM) recorded at ₹1,226 Cr. Notably, the quarterly sales peaked at ₹310 Cr in March 2024, while the lowest point was ₹239 Cr in June 2023. The company’s revenue pattern indicates a recovery trend, with sales improving from ₹263 Cr in September 2023 to ₹328 Cr in September 2024. Despite the volatility, the overall sales trajectory suggests a resilience in demand for agrochemicals, reflecting the sector’s critical role in enhancing agricultural productivity in India.
Profitability and Efficiency Metrics
Bharat Rasayan’s profitability metrics illustrate a mixed performance, with an operating profit margin (OPM) standing at 12% for the current period. The net profit for the last fiscal year was recorded at ₹133 Cr, translating to an earnings per share (EPS) of ₹80.25. The company’s operating profit reached ₹175 Cr in March 2025, indicating some recovery from the lower operating profit of ₹118 Cr in March 2024. The interest coverage ratio (ICR) was exceptionally high at 42.60x, showcasing strong ability to cover interest expenses. However, the OPM has shown volatility, declining to as low as 2% in June 2023. This inconsistency raises concerns about cost management in periods of lower sales, underscoring the necessity for improved operational efficiency.
Balance Sheet Strength and Financial Ratios
Bharat Rasayan’s balance sheet exhibits a robust financial structure, with total reserves amounting to ₹1,193 Cr against borrowings of only ₹90 Cr, indicating a strong equity base and low leverage. The debt-to-equity ratio is notably low at 0.07, demonstrating prudent financial management and minimal reliance on debt financing. The company’s total assets stood at ₹1,456 Cr, reflecting a healthy asset base to support operations. The current ratio of 4.19x further reinforces the company’s liquidity position, significantly above the typical industry benchmark. However, the return on equity (ROE) at 12.4% and return on capital employed (ROCE) at 15.5% are relatively moderate compared to sector leaders, suggesting potential areas for enhancement in capital utilization and shareholder returns.
Shareholding Pattern and Investor Confidence
The shareholding structure of Bharat Rasayan indicates a strong promoter backing, with promoters holding 74.99% of the company. This high level of ownership often correlates with long-term strategic alignment and stability in decision-making. Institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), hold a modest 0.47% and 2.75%, respectively, which reflects cautious investor sentiment in the agrochemical sector. The public shareholding stands at 21.79%, showing a diverse investor base. The decline in the number of shareholders from 17,304 in December 2022 to 15,388 in September 2025 may signal a consolidation of interest among larger shareholders, which can be interpreted as a potential strength, yet also raises concerns about broader market interest in the stock.
Outlook, Risks, and Final Insight
The outlook for Bharat Rasayan appears cautiously optimistic, underpinned by a recovering sales trend and strong balance sheet metrics. However, the company faces risks including fluctuating raw material costs and agricultural market volatility, which could impact profitability. The agrochemical sector is also subject to stringent regulatory changes, which may pose operational challenges. Strengths include a solid financial foundation with low debt levels and strong promoter support, while risks include the need for improved operational efficiency and market expansion strategies. If the company successfully navigates these challenges, it may enhance profitability and shareholder returns, positioning itself as a leader in the agrochemical industry amidst evolving agricultural demands.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 4,825 Cr. | 1,118 | 2,114/1,115 | 12.0 | 487 | 0.54 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 794 Cr. | 235 | 391/165 | 16.3 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 59.9 Cr. | 115 | 149/56.6 | 10.7 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 2,699 Cr. | 208 | 331/198 | 102 | 54.9 | 0.07 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 1,031 Cr. | 436 | 570/244 | 80.5 | 342 | 0.46 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 10,808.10 Cr | 1,101.55 | 31.13 | 382.34 | 0.44% | 15.21% | 19.87% | 7.04 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 292 | 309 | 306 | 239 | 263 | 233 | 310 | 282 | 328 | 256 | 307 | 377 | 286 |
| Expenses | 256 | 260 | 249 | 234 | 250 | 207 | 240 | 244 | 281 | 215 | 270 | 308 | 253 |
| Operating Profit | 36 | 49 | 56 | 6 | 13 | 26 | 69 | 38 | 47 | 42 | 37 | 69 | 33 |
| OPM % | 12% | 16% | 18% | 2% | 5% | 11% | 22% | 14% | 14% | 16% | 12% | 18% | 12% |
| Other Income | 3 | 6 | -3 | 9 | 4 | 4 | 22 | 22 | 7 | 18 | 6 | -8 | 11 |
| Interest | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 7 | 7 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 7 | 7 | 6 | 6 |
| Profit before tax | 31 | 46 | 46 | 8 | 10 | 22 | 84 | 53 | 46 | 52 | 35 | 54 | 36 |
| Tax % | 26% | 27% | 34% | 8% | 39% | 29% | 20% | 19% | 30% | 21% | 27% | 26% | 23% |
| Net Profit | 23 | 34 | 30 | 7 | 6 | 15 | 67 | 43 | 32 | 41 | 25 | 40 | 28 |
| EPS in Rs | 13.81 | 20.34 | 18.22 | 4.27 | 3.61 | 9.22 | 40.43 | 25.98 | 19.36 | 24.42 | 15.14 | 23.89 | 16.80 |
Last Updated: January 2, 2026, 6:03 am
Below is a detailed analysis of the quarterly data for Bharat Rasayan Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 286.00 Cr.. The value appears to be declining and may need further review. It has decreased from 377.00 Cr. (Jun 2025) to 286.00 Cr., marking a decrease of 91.00 Cr..
- For Expenses, as of Sep 2025, the value is 253.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 308.00 Cr. (Jun 2025) to 253.00 Cr., marking a decrease of 55.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 33.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Jun 2025) to 33.00 Cr., marking a decrease of 36.00 Cr..
- For OPM %, as of Sep 2025, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Jun 2025) to 12.00%, marking a decrease of 6.00%.
- For Other Income, as of Sep 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from -8.00 Cr. (Jun 2025) to 11.00 Cr., marking an increase of 19.00 Cr..
- For Interest, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 6.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 36.00 Cr.. The value appears to be declining and may need further review. It has decreased from 54.00 Cr. (Jun 2025) to 36.00 Cr., marking a decrease of 18.00 Cr..
- For Tax %, as of Sep 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Jun 2025) to 23.00%, marking a decrease of 3.00%.
- For Net Profit, as of Sep 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 40.00 Cr. (Jun 2025) to 28.00 Cr., marking a decrease of 12.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 16.80. The value appears to be declining and may need further review. It has decreased from 23.89 (Jun 2025) to 16.80, marking a decrease of 7.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:33 am
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 989 | 1,213 | 1,091 | 1,301 | 1,234 | 1,044 | 1,171 | 1,226 |
| Expenses | 802 | 983 | 852 | 1,050 | 1,043 | 926 | 996 | 1,045 |
| Operating Profit | 188 | 230 | 240 | 250 | 191 | 118 | 175 | 181 |
| OPM % | 19% | 19% | 22% | 19% | 15% | 11% | 15% | 15% |
| Other Income | 1 | 14 | 6 | 16 | 15 | 35 | 42 | 27 |
| Interest | 16 | 16 | 4 | 7 | 6 | 3 | 5 | 5 |
| Depreciation | 17 | 22 | 26 | 25 | 26 | 26 | 27 | 27 |
| Profit before tax | 155 | 205 | 215 | 234 | 174 | 123 | 185 | 176 |
| Tax % | 28% | 23% | 24% | 25% | 28% | 23% | 24% | |
| Net Profit | 112 | 158 | 164 | 176 | 125 | 96 | 141 | 133 |
| EPS in Rs | 65.60 | 92.73 | 96.39 | 106.01 | 75.07 | 57.54 | 84.89 | 80.25 |
| Dividend Payout % | 1% | 0% | 0% | 0% | 0% | 1% | 0% |
YoY Net Profit Growth
| Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 41.07% | 3.80% | 7.32% | -28.98% | -23.20% | 46.88% |
| Change in YoY Net Profit Growth (%) | 0.00% | -37.27% | 3.52% | -36.29% | 5.78% | 70.08% |
Bharat Rasayan Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -1% |
| 3 Years: | -3% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -4% |
| 3 Years: | -9% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 2% |
| 3 Years: | -7% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 12% |
| Last Year: | 12% |
Last Updated: September 5, 2025, 12:55 am
Balance Sheet
Last Updated: December 4, 2025, 1:03 am
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves | 405 | 560 | 723 | 766 | 889 | 984 | 1,126 | 1,193 |
| Borrowings | 247 | 94 | 58 | 174 | 28 | 80 | 85 | 90 |
| Other Liabilities | 100 | 94 | 122 | 142 | 152 | 129 | 193 | 168 |
| Total Liabilities | 756 | 752 | 908 | 1,086 | 1,074 | 1,197 | 1,408 | 1,456 |
| Fixed Assets | 150 | 203 | 191 | 228 | 225 | 230 | 230 | 223 |
| CWIP | 35 | 18 | 18 | 11 | 11 | 6 | 15 | 25 |
| Investments | 0 | 9 | 150 | 43 | 67 | 143 | 298 | 298 |
| Other Assets | 570 | 522 | 549 | 803 | 771 | 818 | 865 | 910 |
| Total Assets | 756 | 752 | 908 | 1,086 | 1,074 | 1,197 | 1,408 | 1,456 |
Below is a detailed analysis of the balance sheet data for Bharat Rasayan Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,193.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,126.00 Cr. (Mar 2025) to 1,193.00 Cr., marking an increase of 67.00 Cr..
- For Borrowings, as of Sep 2025, the value is 90.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 85.00 Cr. (Mar 2025) to 90.00 Cr., marking an increase of 5.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 168.00 Cr.. The value appears to be improving (decreasing). It has decreased from 193.00 Cr. (Mar 2025) to 168.00 Cr., marking a decrease of 25.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,456.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,408.00 Cr. (Mar 2025) to 1,456.00 Cr., marking an increase of 48.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 223.00 Cr.. The value appears to be declining and may need further review. It has decreased from 230.00 Cr. (Mar 2025) to 223.00 Cr., marking a decrease of 7.00 Cr..
- For CWIP, as of Sep 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 10.00 Cr..
- For Investments, as of Sep 2025, the value is 298.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 298.00 Cr..
- For Other Assets, as of Sep 2025, the value is 910.00 Cr.. The value appears strong and on an upward trend. It has increased from 865.00 Cr. (Mar 2025) to 910.00 Cr., marking an increase of 45.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,456.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,408.00 Cr. (Mar 2025) to 1,456.00 Cr., marking an increase of 48.00 Cr..
Notably, the Reserves (1,193.00 Cr.) exceed the Borrowings (90.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -59.00 | 136.00 | 182.00 | 76.00 | 163.00 | 38.00 | 90.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 103 | 75 | 99 | 130 | 96 | 138 | 131 |
| Inventory Days | 112 | 70 | 90 | 120 | 141 | 135 | 136 |
| Days Payable | 24 | 17 | 33 | 30 | 33 | 37 | 67 |
| Cash Conversion Cycle | 191 | 128 | 156 | 221 | 204 | 236 | 200 |
| Working Capital Days | 96 | 94 | 114 | 136 | 165 | 199 | 170 |
| ROCE % | 34% | 31% | 28% | 20% | 12% | 16% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| PGIM India Midcap Fund | 63,964 | 0.58 | 66.54 | N/A | N/A | N/A |
| PGIM India Small Cap Fund | 25,978 | 1.69 | 27.02 | 26,931 | 2025-12-08 02:13:57 | -3.54% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 339.14 | 229.86 | 299.89 | 423.52 | 385.70 |
| Diluted EPS (Rs.) | 339.14 | 229.86 | 299.89 | 423.52 | 385.70 |
| Cash EPS (Rs.) | 366.03 | 258.47 | 377.50 | 486.31 | 447.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 2719.48 | 2377.47 | 2149.86 | 1853.14 | 1711.78 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 2719.48 | 2377.47 | 2149.86 | 1853.14 | 1711.78 |
| Revenue From Operations / Share (Rs.) | 2822.98 | 2514.02 | 2970.60 | 3131.39 | 2570.20 |
| PBDIT / Share (Rs.) | 483.48 | 332.50 | 521.37 | 651.03 | 580.53 |
| PBIT / Share (Rs.) | 418.53 | 270.43 | 458.73 | 591.01 | 519.90 |
| PBT / Share (Rs.) | 407.18 | 263.32 | 433.75 | 565.14 | 508.26 |
| Net Profit / Share (Rs.) | 301.08 | 196.40 | 314.86 | 426.29 | 387.10 |
| NP After MI And SOA / Share (Rs.) | 339.15 | 229.86 | 299.89 | 423.53 | 385.70 |
| PBDIT Margin (%) | 17.12 | 13.22 | 17.55 | 20.79 | 22.58 |
| PBIT Margin (%) | 14.82 | 10.75 | 15.44 | 18.87 | 20.22 |
| PBT Margin (%) | 14.42 | 10.47 | 14.60 | 18.04 | 19.77 |
| Net Profit Margin (%) | 10.66 | 7.81 | 10.59 | 13.61 | 15.06 |
| NP After MI And SOA Margin (%) | 12.01 | 9.14 | 10.09 | 13.52 | 15.00 |
| Return on Networth / Equity (%) | 12.47 | 9.66 | 13.94 | 22.85 | 22.53 |
| Return on Capital Employeed (%) | 15.15 | 11.23 | 21.10 | 31.43 | 29.94 |
| Return On Assets (%) | 10.00 | 7.97 | 11.60 | 16.14 | 18.04 |
| Total Debt / Equity (X) | 0.07 | 0.08 | 0.03 | 0.22 | 0.08 |
| Asset Turnover Ratio (%) | 0.90 | 0.91 | 1.14 | 1.30 | 1.32 |
| Current Ratio (X) | 4.19 | 4.60 | 4.64 | 2.59 | 3.82 |
| Quick Ratio (X) | 3.08 | 3.25 | 2.74 | 1.70 | 2.83 |
| Inventory Turnover Ratio (X) | 4.21 | 2.30 | 2.85 | 4.16 | 4.04 |
| Dividend Payout Ratio (NP) (%) | 0.44 | 0.65 | 0.50 | 0.00 | 0.38 |
| Dividend Payout Ratio (CP) (%) | 0.37 | 0.51 | 0.41 | 0.00 | 0.33 |
| Earning Retention Ratio (%) | 99.56 | 99.35 | 99.50 | 0.00 | 99.62 |
| Cash Earning Retention Ratio (%) | 99.63 | 99.49 | 99.59 | 0.00 | 99.67 |
| Interest Coverage Ratio (X) | 42.60 | 46.73 | 37.31 | 39.68 | 67.02 |
| Interest Coverage Ratio (Post Tax) (X) | 27.53 | 28.60 | 24.32 | 27.56 | 46.03 |
| Enterprise Value (Cr.) | 4407.24 | 3562.69 | 3772.42 | 5228.04 | 4021.85 |
| EV / Net Operating Revenue (X) | 3.76 | 3.41 | 3.06 | 4.02 | 3.68 |
| EV / EBITDA (X) | 21.94 | 25.79 | 17.41 | 19.33 | 16.31 |
| MarketCap / Net Operating Revenue (X) | 3.73 | 3.38 | 3.06 | 3.89 | 3.66 |
| Retention Ratios (%) | 99.55 | 99.34 | 99.49 | 0.00 | 99.61 |
| Price / BV (X) | 3.87 | 3.57 | 4.23 | 6.57 | 5.49 |
| Price / Net Operating Revenue (X) | 3.73 | 3.38 | 3.06 | 3.89 | 3.66 |
| EarningsYield | 0.03 | 0.02 | 0.03 | 0.03 | 0.04 |
After reviewing the key financial ratios for Bharat Rasayan Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 339.14. This value is within the healthy range. It has increased from 229.86 (Mar 24) to 339.14, marking an increase of 109.28.
- For Diluted EPS (Rs.), as of Mar 25, the value is 339.14. This value is within the healthy range. It has increased from 229.86 (Mar 24) to 339.14, marking an increase of 109.28.
- For Cash EPS (Rs.), as of Mar 25, the value is 366.03. This value is within the healthy range. It has increased from 258.47 (Mar 24) to 366.03, marking an increase of 107.56.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,719.48. It has increased from 2,377.47 (Mar 24) to 2,719.48, marking an increase of 342.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,719.48. It has increased from 2,377.47 (Mar 24) to 2,719.48, marking an increase of 342.01.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,822.98. It has increased from 2,514.02 (Mar 24) to 2,822.98, marking an increase of 308.96.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 483.48. This value is within the healthy range. It has increased from 332.50 (Mar 24) to 483.48, marking an increase of 150.98.
- For PBIT / Share (Rs.), as of Mar 25, the value is 418.53. This value is within the healthy range. It has increased from 270.43 (Mar 24) to 418.53, marking an increase of 148.10.
- For PBT / Share (Rs.), as of Mar 25, the value is 407.18. This value is within the healthy range. It has increased from 263.32 (Mar 24) to 407.18, marking an increase of 143.86.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 301.08. This value is within the healthy range. It has increased from 196.40 (Mar 24) to 301.08, marking an increase of 104.68.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 339.15. This value is within the healthy range. It has increased from 229.86 (Mar 24) to 339.15, marking an increase of 109.29.
- For PBDIT Margin (%), as of Mar 25, the value is 17.12. This value is within the healthy range. It has increased from 13.22 (Mar 24) to 17.12, marking an increase of 3.90.
- For PBIT Margin (%), as of Mar 25, the value is 14.82. This value is within the healthy range. It has increased from 10.75 (Mar 24) to 14.82, marking an increase of 4.07.
- For PBT Margin (%), as of Mar 25, the value is 14.42. This value is within the healthy range. It has increased from 10.47 (Mar 24) to 14.42, marking an increase of 3.95.
- For Net Profit Margin (%), as of Mar 25, the value is 10.66. This value exceeds the healthy maximum of 10. It has increased from 7.81 (Mar 24) to 10.66, marking an increase of 2.85.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.01. This value is within the healthy range. It has increased from 9.14 (Mar 24) to 12.01, marking an increase of 2.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.47. This value is below the healthy minimum of 15. It has increased from 9.66 (Mar 24) to 12.47, marking an increase of 2.81.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.15. This value is within the healthy range. It has increased from 11.23 (Mar 24) to 15.15, marking an increase of 3.92.
- For Return On Assets (%), as of Mar 25, the value is 10.00. This value is within the healthy range. It has increased from 7.97 (Mar 24) to 10.00, marking an increase of 2.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.07. This value is within the healthy range. It has decreased from 0.08 (Mar 24) to 0.07, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.90. It has decreased from 0.91 (Mar 24) to 0.90, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 4.19. This value exceeds the healthy maximum of 3. It has decreased from 4.60 (Mar 24) to 4.19, marking a decrease of 0.41.
- For Quick Ratio (X), as of Mar 25, the value is 3.08. This value exceeds the healthy maximum of 2. It has decreased from 3.25 (Mar 24) to 3.08, marking a decrease of 0.17.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.21. This value is within the healthy range. It has increased from 2.30 (Mar 24) to 4.21, marking an increase of 1.91.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 20. It has decreased from 0.65 (Mar 24) to 0.44, marking a decrease of 0.21.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 20. It has decreased from 0.51 (Mar 24) to 0.37, marking a decrease of 0.14.
- For Earning Retention Ratio (%), as of Mar 25, the value is 99.56. This value exceeds the healthy maximum of 70. It has increased from 99.35 (Mar 24) to 99.56, marking an increase of 0.21.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 99.63. This value exceeds the healthy maximum of 70. It has increased from 99.49 (Mar 24) to 99.63, marking an increase of 0.14.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 42.60. This value is within the healthy range. It has decreased from 46.73 (Mar 24) to 42.60, marking a decrease of 4.13.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 27.53. This value is within the healthy range. It has decreased from 28.60 (Mar 24) to 27.53, marking a decrease of 1.07.
- For Enterprise Value (Cr.), as of Mar 25, the value is 4,407.24. It has increased from 3,562.69 (Mar 24) to 4,407.24, marking an increase of 844.55.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.76. This value exceeds the healthy maximum of 3. It has increased from 3.41 (Mar 24) to 3.76, marking an increase of 0.35.
- For EV / EBITDA (X), as of Mar 25, the value is 21.94. This value exceeds the healthy maximum of 15. It has decreased from 25.79 (Mar 24) to 21.94, marking a decrease of 3.85.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 3. It has increased from 3.38 (Mar 24) to 3.73, marking an increase of 0.35.
- For Retention Ratios (%), as of Mar 25, the value is 99.55. This value exceeds the healthy maximum of 70. It has increased from 99.34 (Mar 24) to 99.55, marking an increase of 0.21.
- For Price / BV (X), as of Mar 25, the value is 3.87. This value exceeds the healthy maximum of 3. It has increased from 3.57 (Mar 24) to 3.87, marking an increase of 0.30.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 3. It has increased from 3.38 (Mar 24) to 3.73, marking an increase of 0.35.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bharat Rasayan Ltd:
- Net Profit Margin: 10.66%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.15% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.47% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 27.53
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24.4 (Industry average Stock P/E: 31.13)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.07
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.66%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | 1501, Vikram Tower, New Delhi Delhi 110008 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sat Narain Gupta | Chairman & Managing Director |
| Mr. Mahabir Prasad Gupta | Whole Time Director |
| Mr. Rajender Prasad Gupta | WholeTime Director & CEO |
| Mr. Ajay Gupta | Executive Director |
| Mr. Kamleshwar Prasad Uniyal | Executive Director |
| Mr. Suresh Kumar Garg | Ind. Non-Executive Director |
| Mr. Ankit Aggarwal | Ind. Non-Executive Director |
| Ms. Mukta Gupta | Ind. Non-Executive Director |
| Mr. Rajesh Gupta | Ind. Non-Executive Director |
| Mr. Naman Jain | Ind. Non-Executive Director |
| Mr. Upendra Singh | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Bharat Rasayan Ltd?
Bharat Rasayan Ltd's intrinsic value (as of 10 January 2026) is ₹1745.52 which is 17.16% lower the current market price of ₹2,107.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,502 Cr. market cap, FY2025-2026 high/low of ₹3,030/2,068, reserves of ₹1,193 Cr, and liabilities of ₹1,456 Cr.
What is the Market Cap of Bharat Rasayan Ltd?
The Market Cap of Bharat Rasayan Ltd is 3,502 Cr..
What is the current Stock Price of Bharat Rasayan Ltd as on 10 January 2026?
The current stock price of Bharat Rasayan Ltd as on 10 January 2026 is ₹2,107.
What is the High / Low of Bharat Rasayan Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bharat Rasayan Ltd stocks is ₹3,030/2,068.
What is the Stock P/E of Bharat Rasayan Ltd?
The Stock P/E of Bharat Rasayan Ltd is 24.4.
What is the Book Value of Bharat Rasayan Ltd?
The Book Value of Bharat Rasayan Ltd is 721.
What is the Dividend Yield of Bharat Rasayan Ltd?
The Dividend Yield of Bharat Rasayan Ltd is 0.02 %.
What is the ROCE of Bharat Rasayan Ltd?
The ROCE of Bharat Rasayan Ltd is 15.5 %.
What is the ROE of Bharat Rasayan Ltd?
The ROE of Bharat Rasayan Ltd is 12.4 %.
What is the Face Value of Bharat Rasayan Ltd?
The Face Value of Bharat Rasayan Ltd is 5.00.